Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019.
J Vasc Surg Venous Lymphat Disord
; 10(1): 14-17, 2022 01.
Article
em En
| MEDLINE
| ID: mdl-34352418
ABSTRACT
Since December 2020, four vaccines for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) have been developed, and three have been approved for immediate use in the United States. Two are mRNA vaccines, and one uses a viral vector mechanism. Thrombotic complications have been reported after vaccine administration, which were primarily cerebral sinus thromboses after administration of the viral vector vaccines. To the best of our knowledge, we are the first to report venous thrombotic complications within days of administration of the mRNA-1273 (Moderna) vaccine. We present a series of three women who developed venous thromboembolism after RNA-1273 vaccination at a single healthcare system.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vacinação
/
Tromboembolia Venosa
/
SARS-CoV-2
/
COVID-19
/
Vacina de mRNA-1273 contra 2019-nCoV
Tipo de estudo:
Diagnostic_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
Idioma:
En
Revista:
J Vasc Surg Venous Lymphat Disord
Ano de publicação:
2022
Tipo de documento:
Article